CO-FLOW: COvid-19 Follow-up care paths and Long-term Outcomes Within the Dutch health care system: study protocol of a multicenter prospective cohort study following patients 2 years after hospital discharge
Abstract Background First studies indicate that up to 6 months after hospital discharge, coronavirus disease 2019 (COVID-19) causes severe physical, cognitive, and psychological impairments, which may affect participation and health-related quality of life (HRQoL). After hospitalization for COVID-19...
সংরক্ষণ করুন:
প্রধান লেখক: | , , , , , , , , , , , |
---|---|
বিন্যাস: | গ্রন্থ |
প্রকাশিত: |
BMC,
2021-08-01T00:00:00Z.
|
বিষয়গুলি: | |
অনলাইন ব্যবহার করুন: | Connect to this object online. |
ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_91b3bbf8a01b4220bfc29bd6114316e7 | ||
042 | |a dc | ||
100 | 1 | 0 | |a L. Martine Bek |e author |
700 | 1 | 0 | |a Julia C. Berentschot |e author |
700 | 1 | 0 | |a Merel E. Hellemons |e author |
700 | 1 | 0 | |a Susanne M. Huijts |e author |
700 | 1 | 0 | |a Joachim G. J. V. Aerts |e author |
700 | 1 | 0 | |a Jasper van Bommel |e author |
700 | 1 | 0 | |a Michel E. van Genderen |e author |
700 | 1 | 0 | |a Diederik A. M. P. J. Gommers |e author |
700 | 1 | 0 | |a Gerard M. Ribbers |e author |
700 | 1 | 0 | |a Majanka H. Heijenbrok-Kal |e author |
700 | 1 | 0 | |a Rita J. G. van den Berg-Emons |e author |
700 | 1 | 0 | |a the CO-FLOW Collaboration Group |e author |
245 | 0 | 0 | |a CO-FLOW: COvid-19 Follow-up care paths and Long-term Outcomes Within the Dutch health care system: study protocol of a multicenter prospective cohort study following patients 2 years after hospital discharge |
260 | |b BMC, |c 2021-08-01T00:00:00Z. | ||
500 | |a 10.1186/s12913-021-06813-6 | ||
500 | |a 1472-6963 | ||
520 | |a Abstract Background First studies indicate that up to 6 months after hospital discharge, coronavirus disease 2019 (COVID-19) causes severe physical, cognitive, and psychological impairments, which may affect participation and health-related quality of life (HRQoL). After hospitalization for COVID-19, a number of patients are referred to medical rehabilitation centers or skilled nursing facilities for further treatment, while others go home with or without aftercare. The aftercare paths include 1] community-based rehabilitation; 2] in- and outpatient medical rehabilitation; 3] inpatient rehabilitation in skilled nursing facilities; and 4] sheltered care (inpatient). These aftercare paths and the trajectories of recovery after COVID-19 urgently need long-term in-depth evaluation to optimize and personalize treatment. CO-FLOW aims, by following the outcomes and aftercare paths of all COVID-19 patients after hospital discharge, to systematically study over a 2-year period: 1] trajectories of physical, cognitive, and psychological recovery; 2] patient flows, healthcare utilization, patient satisfaction with aftercare, and barriers/facilitators regarding aftercare as experienced by healthcare professionals; 3] effects of physical, cognitive, and psychological outcomes on participation and HRQoL; and 4] predictors for long-term recovery, health care utilization, and patient satisfaction with aftercare. Methods CO-FLOW is a multicenter prospective cohort study in the mid-west of the Netherlands with a 2-year follow-up period. Measurements comprise non-invasive clinical tests and patient reported outcome measures from a combined rehabilitation, pulmonary, and intensive care perspective. Measurements are performed at 3, 6, 12, and 24 months after hospital discharge and, if applicable, at rehabilitation discharge. CO-FLOW aims to include at least 500 patients who survived hospitalization for COVID-19, aged ≥18 years. Discussion CO-FLOW will provide in-depth knowledge on the long-term sequelae of COVID-19 and the quality of current aftercare paths for patients who survived hospitalization. This knowledge is a prerequisite to facilitate the right care in the right place for COVID-19 and comparable future infectious diseases. Trial registration The Netherlands Trial Register (NTR), https://www.trialregister.nl . Registered: 12-06-2020, CO-FLOW trialregister no. NL8710. | ||
546 | |a EN | ||
690 | |a COVID-19 | ||
690 | |a Aftercare paths | ||
690 | |a Physical recovery | ||
690 | |a Cognitive recovery | ||
690 | |a Psychosocial recovery | ||
690 | |a Participation | ||
690 | |a Public aspects of medicine | ||
690 | |a RA1-1270 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n BMC Health Services Research, Vol 21, Iss 1, Pp 1-10 (2021) | |
787 | 0 | |n https://doi.org/10.1186/s12913-021-06813-6 | |
787 | 0 | |n https://doaj.org/toc/1472-6963 | |
856 | 4 | 1 | |u https://doaj.org/article/91b3bbf8a01b4220bfc29bd6114316e7 |z Connect to this object online. |